noscript

News and Announcements

Case Studies of Analytica’s PeriCoach Published in Peer Reviewed Urology Journal

  • Published May 20, 2016 10:20AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

19th May 2016, ASX Announcement

Analytica Ltd (ASX: ALT) manufacturer of the PeriCoach® System is pleased announce the publication of case studies describing pelvic floor training with Pericoach in the Urologic Nursing Journal of the US Society of Urologic Nurses and Associates.

Clinical support and publication in a leading peer review journal is a significant milestone for the Company and is a direct reflection of executing its strategy to obtain clinical evidence of PeriCoach.

The journal articles are authorised by US Nurse Practitioner (NP) Julie Starr and Physiotherapist (PT) Beth Shelley. The articles are based on two separate case studies which were conducted to demonstrate the efficacy and ease of the use of PeriCoach in the treatment of common pelvic floor dysfunctions such as urinary incontinence and pelvic organ prolapse, as well as the emotional and lifestyle benefits of restoring pelvic floor strength.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now